Launch ShowcaseWin a Polaris merch box when you upload a dataset or benchmark! Learn more.

Dataset

polaris/kinase-pkis2-1

A subset of PKIS 2 dataset only including EGFR, RET, KIT, LOK and SLK kinases. Profile of kinases PKIS2 which contains 640 small molecule for 468 kinases.

Created on: December 08, 2023Dataset size: 56 KBNumber of datapoints: 640
Public

Explore the dataset columns

KIT

Description: Percentage of inhibition on KIT wide typeType: float64

AttributeValue
unit%
sourcePKIS2
targetKIT
mutationNone
organismHuman
objectiveHigher value
concentration1uM

Details

README

molprop

Background:

Kinases play a crucial role in cellular signalling, making them important targets for drug development. Dysregulation of kinases is frequently implicated in diseases like cancer, inflammation, and neurodegenerative disorders. Therefore, targeting kinases with specific drugs has emerged as a crucial strategy in modern drug discovery. Kinase-related task includes inhibition prediction, selectivity prediction, or kinase-ligand binding affinity prediction. In the early release version of Polaris, benchmarks were established for kinases such as EGFR, KIT, and RET, along with their respective mutations, as well as for LOK and SLK.

Description of readout

  • Readouts: EGFR, KIT, RET, LOK, SLK
  • Bioassay readout: Percentage of inhibition (%).
  • Optimization objective: Higher potency (higher %inhibition).
  • Number of molecules after curation: 640

Data resource:

PKIS2: A second chemogenomics set of kinase inhibitors from GSK, Takeda, and Pfizer was assembled as PKIS2. This set contained 645 inhibitors and included many additional chemotypes that were not represented in the original set.

Reference: https://www.ncbi.nlm.nih.gov/pubmed/28767711

Data curation

To maintain consistency with other benchmarks in the Polaris Hub, a thorough data curation process is carried out to ensure the accuracy of molecular presentations.

The full curation and creation process is documented here.